Cagrilintide is a long-acting amylin receptor agonist designed by Novo Nordisk for body weight administration and metabolic wellbeing. It mimics the action of naturally occurring amylin hormone, which is co-secreted with insulin from pancreatic beta cells. → Constipation or abdominal discomfort: Slowed gastric emptying can in some cases lead to https://cagrilintide-structure01477.blogacep.com/45507978/detailed-notes-on-cagrilintide